Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar with DF chemotherapy and IMRT in advanced NPC
NCT02444949Phase 2Completed
- Sponsor
- China Three Gorges University
- Start
- Jun 2014
- Primary completion
- Dec 2016
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of endostar in nasopharyngeal carcinoma (NPC), sponsored by China Three Gorges University. Started Jun 2014; status: completed.
02
Drugs
endostar
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02444949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02444949.